Autophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast Cancer

While breast cancer patients benefit from the use of HER2 inhibitors, many fail therapy and become resistant to treatment, indicating a critical need to prevent treatment failure. A number of studies have emerged that highlight the catabolic process of autophagy in breast cancer as a mechanism of re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zambrano, Joelle, Yeh, Elizabeth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790584/
https://www.ncbi.nlm.nih.gov/pubmed/26997868
http://dx.doi.org/10.4137/BCBCR.S32791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790584/
https://www.ncbi.nlm.nih.gov/pubmed/26997868
http://dx.doi.org/10.4137/BCBCR.S32791

Ejemplares similares